Patrick Mosler
YOU?
Author Swipe
View article: Effectiveness and safety of first-line empirical Helicobacter pylori eradication regimens in Switzerland: an interim analysis from a prospective multicentre registry (Hp-EuReg)
Effectiveness and safety of first-line empirical Helicobacter pylori eradication regimens in Switzerland: an interim analysis from a prospective multicentre registry (Hp-EuReg) Open
BACKGROUND: Helicobacter pylori infection remains prevalent globally. Despite the relatively low reported prevalence in Switzerland, the actual burden is thought to be higher, primarily due to migration. To date, limited evidence is availa…
View article: Evaluating the Cost-Effectiveness of Early Compared with Late or No Biologic Treatment to Manage Crohn’s Disease using Real-World Data
Evaluating the Cost-Effectiveness of Early Compared with Late or No Biologic Treatment to Manage Crohn’s Disease using Real-World Data Open
Background and Aims We evaluated the cost-effectiveness of early [≤2 years after diagnosis] compared with late or no biologic initiation [starting biologics >2 years after diagnosis or no biologic use] for adults with Crohn’s disease in…
View article: Cohort Profile Update: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS)
Cohort Profile Update: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS) Open
The SIBDCS was launched in November 2006 with the aim of enrolling and following patients with inflammatory bowel disease (IBD) throughout Switzerland. Our original sample included incident or prevalent cases, regularly treated in Switzerl…
View article: Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study
Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study Open
Background: The knowledge about risk factors for the onset of uveitis manifestations in patients with inflammatory bowel disease (IBD) is still limited. Here, we aimed to provide an overview of the clinical factors associated with the onse…
View article: The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort
The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort Open
Our data indicate that due to frequent occurrence of deficiency states, regular monitoring and substitution of vitamins and iron are mandatory and may prevent long-term intestinal and extraintestinal complications in IBD patients.
View article: Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study
Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study Open
Crude and adjusted colectomy rates in Swiss UC patients were lower than those reported previously in the literature, and decreased over time.